These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6478659)

  • 1. The hematological response to continuous ambulatory peritoneal dialysis.
    Saltissi D; Coles GA; Napier JA; Bentley P
    Clin Nephrol; 1984 Jul; 22(1):21-7. PubMed ID: 6478659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of CAPD-treated patients without anemia].
    Majdan M; Grzebalska AM; Mierzicki P; Berger-Smyka B; Bober E; Orłowska A; Ksiazek A
    Wiad Lek; 2003; 56(1-2):14-8. PubMed ID: 12901262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
    Pilkey RM; Morton AR; Iliescu EA
    Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin in children with chronic renal failure on dialytic and non-dialytic therapy.
    Aikhionbare HA; Winterborn MW; Gyde OH
    Int J Pediatr Nephrol; 1987; 8(1):9-14. PubMed ID: 3583560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous erythropoietin in the treatment of renal anaemia.
    Drinovec J; Varl J
    Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium term response to H-R erythropoietin in CAPD patients: the influence of erythropoietin plasmatic levels and the effects on peritoneal transport capacity.
    Bajo MA; Selgas R; Miranda B; Fernandez-Zamorano A; Borrego F; Romero JR; Caparros G; Riñon C; Sanchez Sicilia L
    Adv Perit Dial; 1991; 7():296-300. PubMed ID: 1680450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
    Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
    Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased need of erythropoietin during peritonitis in children on continuous peritoneal dialysis.
    Amon O; Altrogge H; Kemper M; Strehlau J; Müller-Wiefel DE
    Adv Perit Dial; 1994; 10():318-20. PubMed ID: 7999857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
    J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is it necessary to supplement with folic acid patients in chronic dialysis treated with erythropoietin?].
    Duclos J; Sieberth HG; Mann H
    Rev Med Chil; 1993 Jan; 121(1):30-5. PubMed ID: 8235161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients.
    Marcovici O; Boner G; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoiesis in the anaemia of chronic renal failure: the response to CAPD.
    Coles GA; Cavill I
    Nephrol Dial Transplant; 1986; 1(3):170-4. PubMed ID: 3110671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M; Bartlett DK; Brier ME; Golper TA
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE; Mariak I
    Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis.
    Siu YP; Leung KT; Tong MK; Kwan TH; Mok CC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2797-802. PubMed ID: 16204302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.